These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 9212813)
1. [An anaphylactic shock case after hepatic arterial infusion of zinostatin stimalamer suspension improved by anti-histaminics]. Fukuhara K; Suzuki M; Unno M; Rikiyama T; Sakamoto N; Takeuchi H; Uchiyama T; Yamaki T; Iwasashi H; Kodama H; Matsuno S Gan To Kagaku Ryoho; 1997 Jun; 24(8):1023-6. PubMed ID: 9212813 [TBL] [Abstract][Full Text] [Related]
2. [Arterial infusion of SMANCS-Lipiodol for advanced hepatocellular carcinoma]. Miura K; Nakao N; Yoshimoto A; Yamano T; Inoue J; Takayasu Y Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():51-5. PubMed ID: 9512688 [TBL] [Abstract][Full Text] [Related]
3. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma]. Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684 [TBL] [Abstract][Full Text] [Related]
4. [Advantages and disadvantages of SMANCS-Lipiodol intrahepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma]. Suzuki M; Fukuhara K; Unno M; Endoh K; Takeuchi H; Kodama H; Oikawa M; Matsuno S Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():39-45. PubMed ID: 9512686 [TBL] [Abstract][Full Text] [Related]
5. [Comparative studies on the antitumor activities and side effects of segmental SMANCS/Lip-TAE with segmental SMANCS/Lip-TAI for hepatocellular carcinoma]. Matoba M; Okimura T; Yamamoto I Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():73-9. PubMed ID: 9512692 [TBL] [Abstract][Full Text] [Related]
6. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma]. Jin-no K Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695 [TBL] [Abstract][Full Text] [Related]
7. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma]. Hirashima N Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700 [TBL] [Abstract][Full Text] [Related]
8. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma]. Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683 [TBL] [Abstract][Full Text] [Related]
9. [A successful treatment using SMANCS-TAE for hepatocellular carcinoma with tumor thrombus in the portal trunk]. Fukushima M; Fukutomi T; Tanabe Y; Hiroshige K; Yoshida K Gan To Kagaku Ryoho; 1996 Jul; 23(8):1073-6. PubMed ID: 8687225 [TBL] [Abstract][Full Text] [Related]
10. [Arterial infusion of SMANCS for multiple recurrent tumors after hepatic resection]. Takano S; Kono S; Iwai S Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():34-8. PubMed ID: 9512685 [TBL] [Abstract][Full Text] [Related]
11. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method]. Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522 [TBL] [Abstract][Full Text] [Related]
12. [Intra-arterial infusion of SMANCS for treatment of patients with hepatocellular carcinoma--adverse reactions and complications]. Sakaguchi T; Yoshimatsu S; Sagara K; Yamashita Y; Takahashi M Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():64-9. PubMed ID: 9512690 [TBL] [Abstract][Full Text] [Related]
13. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol]. Inoue Y; Nakamura H Gan To Kagaku Ryoho; 1996 Jan; 23(1):99-101. PubMed ID: 8546478 [TBL] [Abstract][Full Text] [Related]
14. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol]. Konno T; Tabaru K; Isogai M; Nagamitsu A; Oda T Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681 [TBL] [Abstract][Full Text] [Related]
15. [Our initial experience with SMANCS in TAE for liver cancer]. Fujita M; Inoue E; Kuroda C; Kasugai H; Sasaki Y; Nakano H; Imaoka S Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():105-8. PubMed ID: 9512697 [TBL] [Abstract][Full Text] [Related]
16. [Subsegmental transcatheter hepatic arterial embolization under balloon occlusion of the corresponding hepatic vein with SMANCS]. Shibata H; Sogabe M; Tsutsui A; Yokoi T; Morimoto M; Fukuda T; Hayashi S; Muguruma N; Ohkita Y; Okahisa T; Okamura S; Ito S Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():133-40. PubMed ID: 9512701 [TBL] [Abstract][Full Text] [Related]
17. [Phase I study of YM881 (zinostatin stimalamer) suspension by hepatic arterial infusion. Research Group for Intra-arterial Infusion Therapy with YM881]. Taguchi T; Saito T; Ota J; Nakao I; Ohashi K; Nakamura H; Konno T Gan To Kagaku Ryoho; 1991 Aug; 18(10):1657-63. PubMed ID: 1651686 [TBL] [Abstract][Full Text] [Related]
18. [Transcatheter arterial embolization with SMANCS and epiADM for hepatocellular carcinoma]. Ihaya T; Ametani M; Matsusue E Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():109-15. PubMed ID: 9512698 [TBL] [Abstract][Full Text] [Related]
19. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report]. Hasegawa I; Hirashima N Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of transcatheter hepatic segmental or subsegmental infusion of SMANCS for treatment of hepatocellular carcinoma]. Inoue Y; Tomoda K; Oi H; Nakamura H Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():56-63. PubMed ID: 9512689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]